Truist Securities Maintains Hold on GoodRx Holdings, Lowers Price Target to $5.5-Report released on 9th Nov 2023
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Jailendra Singh has maintained a Hold rating on GoodRx Holdings (NASDAQ:GDRX) but lowered the price target from $8 to $5.5.
November 10, 2023 | 3:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Truist Securities has maintained a Hold rating on GoodRx Holdings but reduced the price target from $8 to $5.5, indicating a potential downside or limited upside.
The reduction in price target by Truist Securities reflects a negative outlook on the stock's potential performance, which could lead to a decrease in investor confidence and a possible short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100